Glimzab MP2

Glimepiride 1 / 2mg +Metformin SR 500mg + Pioglitazone 15mg

Description:

Glimzab MP2 is a combination of three antidiabetic medicines: Glimepiride , Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective.
Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose.
Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body’s sensitivity to insulin.
Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.

Indications:

Used in the treatment of Type 2 Diabetes Mellitus (DM).

Composition:

Glimzab MP2

Composition :
Each uncoated bilayered tablet contains:
Glimepiride IP 2mg
Pioglitazone Hydrochloride IP
Eq. to Pioglitazone 15mg
Metformin Hydrochloride IP 500mg
(in sustained release form)
Excipients q.s.
Colour : Lake of Quinoline Yellow WS